Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 5Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 25Small Cell Lung Carcinoma 23Leukemia 18Lymphoma, Large B-Cell, Diffuse 17Lung Neoplasms 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Non-Hodgkin 14Lymphoma, Extranodal NK-T-Cell 11Hodgkin Disease 10Leukemia, Myeloid, Acute 8Carcinoma, Non-Small-Cell Lung 8Ovarian Neoplasms 7Neuroblastoma 7Lymphoma, Mantle-Cell 7Burkitt Lymphoma 7Recurrence 6Lymphoma, T-Cell, Peripheral 6Central Nervous System Neoplasms 6Retinoblastoma 5Lymphoma, Large-Cell, Immunoblastic 5Lymphohistiocytosis, Hemophagocytic 5Breast Neoplasms 5Testicular Neoplasms 4Multiple Myeloma 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Teratoma 3

Interventions

Temozolomide 7Radiotherapy 5Vincristine 3Cisplatin 3Carmustine 3Carboplatin 3Methotrexate 2Cyclophosphamide 2Chlorotoxin 2lonafarnib 1Verteporfin 1Thiotepa 1Surgical Procedures, Operative 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Metabolism 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Gelclair 1Etoposide 1Ethanol 1Arsenic Trioxide 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Oligodendroglioma × Etoposide × Clear all
NCT00392886 2013-12-18

Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors

National Cancer Institute (NCI)

Phase 3 Unknown
120 enrolled
CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡